中文
|
English
Home
|
Help
|
Contact
Return
Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
10.5217/ir.2019.00070
Author:
Hyuk YOON
1
Author Information
1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. bodnsoul@hanmail.net
Publication Type:
Editorial
MeSH:
Colitis, Ulcerative; Humans; Ulcer
From:
Intestinal Research 2019;17(3):283-284
Country
Republic of Korea
Language:
English
Abstract:
No abstract available.